ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT
Report
- Report Number
- 3005094123-2023-00167
- Event Type
- Malfunction
- Date Received
- July 5, 2023
- Date of Event
- June 12, 2023
- Report Date
- July 25, 2023
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- MMI
- PMA / PMN Number
- N/A
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CO
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 8P13 HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 04Z21.
THE COMPLAINT INVESTIGATION FOR FALSELY ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN-I RESULTS INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TICKET TRENDING REVIEW, LABELING REVIEW, DEVICE HISTORY RECORD REVIEW, FIELD DATA REVIEW, AND IN HOUSE TESTING. RETURN TESTING WAS NOT COMPLETED AS RETURNS WERE NOT AVAILABLE. A REVIEW OF TRACKING AND TRENDING DID NOT IDENTIFY ANY RELATED TRENDS FOR THE PRODUCT FOR THE ISSUE. DEVICE HISTORY RECORD REVIEW ON LOT 49083UD00 DID NOT IDENTIFY ANY NON-CONFORMANCES OR DEVIATIONS ASSOCIATED WITH LOT NUMBER 49083UD00 AND THE COMPLAINT ISSUE. CUSTOMER FIELD DATA WAS USED TO ASSESS THE PERFORMANCE OF THE ARCHITECT STAT HIGH SENSITIVE TROPONIN-I ASSAY USING WORLDWIDE DATA. THE MEDIAN POPULATION RESULT FOR COMPLAINT LOT 49083UD00 ARE WITHIN ESTABLISHED LIMITS, INDICATING THAT THE LOT(S) ARE PERFORMING ACCEPTABLY IN THE FIELD. IN-HOUSE ACCURACY TESTING WAS COMPLETED WITH COMPLAINT LOT NUMBER 49083UD00. ALL SPECIFICATIONS WERE MET INDICATING THAT LOT 49083UD00 IS PERFORMING ACCEPTABLY. LABELING WAS REVIEWED AND FOUND TO ADEQUATELY ADDRESS THE ISSUE UNDER REVIEW. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ALINITY I STAT HIGH SENSITIVE TROPONIN-I FOR LOT NUMBER 49083UD00 WAS IDENTIFIED.
THE CUSTOMER OBSERVED A FALSELY ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN-I RESULT FOR A 48 YEAR OLD MALE PATIENT PRESENTING WITH CHEST PAIN. THE FOLLOWING DATA WAS PROVIDED: (B)(6) 2023, SID (B)(6) , INITIAL RESULT = 93.4 PG/ML. THE PATIENT WAS TRANSFERRED TO THE ICU AND STARTED ON AN ANTI-ISCHEMIC REGIMEN OF INTRAVENOUS NITRATE AND POTASSIUM. ADDITIONALLY, THE FOLLOWING MEDICATION WAS GIVEN: LOSARTAN POTASSIUM (50 MG EVERY 12 HOURS). CLOPIDOGREL (75 MG EVERY 24 HOURS). LOW MOLECULAR WEIGHT HEPARIN (60 MG FOR 24 HOURS). ACETYLSALICYLIC ACID (100 MG / 24 HOURS). A NEW SAMPLE WAS COLLECTED AND GENERATED A NEGATIVE RESULT OF 8.9 PG/ML. THE ORIGINAL SAMPLE WAS REPEATED AND GENERATED A NEGATIVE RESULT OF 11.2 PG/ML. THE ORIGINAL SAMPLE WAS ALSO RUN AT ANOTHER LABORATORY AND GENERATED A NEGATIVE RESULT OF 11.7 PG/ML. THE PATIENT¿S FINAL DIAGNOSIS WAS HIGH-RISK UNSTABLE ANGINA-TYPE ACUTE CORONARY SYNDROME. SCORE GRACE 67 KK I/IV. NO ADDITIONAL IMPACT TO PATIENT MANAGEMENT WAS REPORTED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
THE CUSTOMER OBSERVED A FALSELY ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN-I RESULT FOR A 48 YEAR OLD MALE PATIENT PRESENTING WITH CHEST PAIN. THE FOLLOWING DATA WAS PROVIDED: 12JUN2023 SID (B)(6) INITIAL RESULT = 93.4 PG/ML THE PATIENT WAS TRANSFERRED TO THE ICU AND STARTED ON AN ANTI-ISCHEMIC REGIMEN OF INTRAVENOUS NITRATE AND POTASSIUM. ADDITIONALLY, THE FOLLOWING MEDICATION WAS GIVEN: LOSARTAN POTASSIUM (50 MG EVERY 12 HOURS). CLOPIDOGREL (75 MG EVERY 24 HOURS). LOW MOLECULAR WEIGHT HEPARIN (60 MG FOR 24 HOURS). ACETYLSALICYLIC ACID (100 MG / 24 HOURS). A NEW SAMPLE WAS COLLECTED AND GENERATED A NEGATIVE RESULT OF 8.9 PG/ML. THE ORIGINAL SAMPLE WAS REPEATED AND GENERATED A NEGATIVE RESULT OF 11.2 PG/ML. THE ORIGINAL SAMPLE WAS ALSO RUN AT ANOTHER LABORATORY AND GENERATED A NEGATIVE RESULT OF 11.7 PG/ML. THE PATIENT¿S FINAL DIAGNOSIS WAS HIGH-RISK UNSTABLE ANGINA-TYPE ACUTE CORONARY SYNDROME. SCORE GRACE 67 KK I/IV. NO ADDITIONAL IMPACT TO PATIENT MANAGEMENT WAS REPORTED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 417717 | ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT | IMMUNOASSAY METHOD, TROPONIN SUBUNIT | MMI | ABBOTT IRELAND DIAGNOSTICS DIVISION | 49083UD00 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 48 YR | Male | ALNTY I PROCESSING MODU, 03R65-01, AI02312| ALNTY I PROCESSING MODU, 03R65-01, AI02312 |